The B2B gateway is a system interface that can be used to electronically send and receive suspected adverse drug reaction reports (individual case safety reports, ICSR) in E2B format. This service is designed to appeal particularly to marketing authorisation holders who send a large number of reports.
Users must also have an IT infrastructure that is suitable for linking up to the Swissmedic B2B gateway.